| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| May 6, 2026 | ±2.2% | -2.5% | under-priced |
| November 4, 2025 | ±1.9% | +0.4% | over-priced |
| July 31, 2025 | ±1.4% | +1.5% | under-priced |
| May 1, 2025 | ±1.6% | -0.6% | over-priced |
| October 30, 2024 | ±1.6% | +0.4% | over-priced |
| August 1, 2024 | ±1.6% | +2.9% | under-priced |
| May 2, 2024 | ±1.8% | +0.1% | over-priced |
| November 2, 2023 | ±2.1% | +3.0% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $0.90 | $7.2B | $919M |
| Q4 FY2025 | — | $5.4B | $594M |
| Q3 FY2025 | $0.86 | $6.7B | $875M |
| Q2 FY2025 | $0.39 | $5.4B | $391M |
Exelon Corporation (EXC) reports in 100 days, with the next report estimated for September 21, 2026. Across the last 8 reports, options priced an average ±1.8% earnings move while the stock actually moved 1.4% on average — the market has been roughly fair on EXC's earnings risk. Fundamentals into the print: EPS up 0.0% year-over-year, revenue up 7.9%. QuantLogix's live 5-factor engine currently reads EXC as a buy at 65/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →